Scholtz & Company LLC Acquires 3,655 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Scholtz & Company LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,305 shares of the healthcare conglomerate’s stock after purchasing an additional 3,655 shares during the period. UnitedHealth Group comprises about 6.3% of Scholtz & Company LLC’s portfolio, making the stock its 3rd largest position. Scholtz & Company LLC’s holdings in UnitedHealth Group were worth $12,796,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Texas Capital Bancshares Inc TX increased its holdings in UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after acquiring an additional 19 shares in the last quarter. Tealwood Asset Management Inc. grew its holdings in UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after buying an additional 19 shares in the last quarter. Atlas Private Wealth Advisors grew its holdings in UnitedHealth Group by 1.1% during the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after buying an additional 19 shares in the last quarter. Prentice Wealth Management LLC grew its holdings in UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after buying an additional 19 shares in the last quarter. Finally, Baker Avenue Asset Management LP grew its holdings in UnitedHealth Group by 1.7% during the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock valued at $615,000 after buying an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 2.2 %

Shares of NYSE:UNH traded down $11.23 on Friday, hitting $490.69. 3,416,349 shares of the company’s stock were exchanged, compared to its average volume of 3,176,139. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock has a market capitalization of $451.63 billion, a price-to-earnings ratio of 29.99, a price-to-earnings-growth ratio of 1.42 and a beta of 0.58. The business’s 50 day simple moving average is $490.35 and its two-hundred day simple moving average is $507.82. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be issued a $2.10 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.71%. The ex-dividend date is Friday, June 14th. UnitedHealth Group’s payout ratio is presently 45.97%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Piper Sandler raised their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, May 31st. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $578.75.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.